We are live on ! Find out more
ZEPP

Zepp Health

26 hedge funds and large institutions have $12.9M invested in Zepp Health in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

0.24% less ownership

Funds ownership: 1.92%1.69% (-0.24%)

7% less capital invested

Capital invested by funds: $13.9M → $12.9M (-$1.01M)

21% less funds holding

Funds holding: 3326 (-7)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
26
Holders Change
-7
Holders Change %
-21.21%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
7
Closed
9
Calls
Puts
Net Calls
Net Calls Change

ZEPP Hedge Fund Activity: Q4 2022 in Review

26 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Zepp Health (ZEPP) for Q4 2022, worth a combined $12.9M — down 7.3% from $13.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ZEPP and 3 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Citadel Advisors, adding an estimated $39.5K. The largest seller was Allspring Global Investments, cutting an estimated $713K.

  • 26 institutional investors held Zepp Health (ZEPP) as of Q4 2022, down from 33 in Q3 2022.
  • Funds reported $12.9M of Zepp Health stock for Q4 2022, down 7.3% quarter-over-quarter.
  • 3 funds opened new Zepp Health positions in Q4 2022 and 9 closed out, a net change of -6 holders.
  • The largest Zepp Health buyer in Q4 2022 was Citadel Advisors, an estimated $39.5K added.
  • The largest Zepp Health seller in Q4 2022 was Allspring Global Investments, an estimated $713K sold.

Based on aggregated 13F filings for Q4 2022.